| Title |
Osimertinib-Induced Cardiotoxicity A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)
|
|---|---|
| Published in |
JACC: CardioOncology, December 2019
|
| DOI | 10.1016/j.jaccao.2019.10.006 |
| Pubmed ID | |
| Authors |
Kartik Anand, Joe Ensor, Barry Trachtenberg, Eric H. Bernicker |
X Demographics
The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 18 | 43% |
| Spain | 4 | 10% |
| Japan | 1 | 2% |
| Mexico | 1 | 2% |
| Argentina | 1 | 2% |
| United Kingdom | 1 | 2% |
| Colombia | 1 | 2% |
| Algeria | 1 | 2% |
| Australia | 1 | 2% |
| Other | 3 | 7% |
| Unknown | 10 | 24% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 25 | 60% |
| Practitioners (doctors, other healthcare professionals) | 10 | 24% |
| Scientists | 6 | 14% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 55 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 13% |
| Student > Ph. D. Student | 6 | 11% |
| Student > Bachelor | 5 | 9% |
| Researcher | 5 | 9% |
| Other | 5 | 9% |
| Other | 10 | 18% |
| Unknown | 17 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 18 | 33% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 13% |
| Biochemistry, Genetics and Molecular Biology | 4 | 7% |
| Agricultural and Biological Sciences | 2 | 4% |
| Nursing and Health Professions | 2 | 4% |
| Other | 3 | 5% |
| Unknown | 19 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2022.
All research outputs
#1,624,687
of 25,724,500 outputs
Outputs from JACC: CardioOncology
#146
of 470 outputs
Outputs of similar age
#38,029
of 467,360 outputs
Outputs of similar age from JACC: CardioOncology
#11
of 30 outputs
Altmetric has tracked 25,724,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 470 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.9. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 467,360 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.